FDA Scientific Public Workshop: Next-Generation Sequencing for Adventitious Agent Detection in Biologics
Discuss the readiness of NGS technologies for AA detection, examine current challenges, and explore adoption of NGS-based methodologies.
Discuss the readiness of NGS technologies for AA detection, examine current challenges, and explore adoption of NGS-based methodologies.
Discuss chemical characterization testing methodologies used to address biocompatibility endpoints for medical devices.